Results 11 to 20 of about 62,608 (262)
BMC Endocrine Disorders, 2020 Background Pituitary adenomas as multifactorial intracranial neoplasms impose a massive burden of morbidity on patients and characterizing the molecular mechanism underlying their pathogenesis has received considerable attention.
Nasrin Akbari +9 more
doaj +1 more source
Pituitary blastoma, expanding the spectrum of newly recognized entities. A case report
Indian Journal of Pathology and Microbiology, 2022 Tumors of the pituitary gland and sellar region represent about 15% of all brain tumors, with pituitary adenoma being the commonest and pituitary carcinoma being very rare. Pituitary tumors in children are even rarer.
Meenakshi Swain +2 more
doaj +1 more source
Frontiers in Surgery, 2022 In the pituitary sella, the coexistence of pituitary adenoma and primary pituitary lymphoma is exceedingly rare. Thus far, only six cases have been reported. Here, we present the seventh case of coexisting pituitary adenoma and primary pituitary lymphoma,
Shangjun Ren +6 more
doaj +1 more source
Aggressive Pituitary Tumors [PDF]
Neuroendocrinology, 2015 Pituitary adenomas are common intracranial tumors that are mainly considered as benign. Rarely, these tumors can exhibit an aggressive behavior, characterized by gross invasion of the surrounding tissues, resistance to conventional treatment leading to early and frequent recurrences.
Chatzellis, E. +3 more
openaire +3 more sources
Zhongliu Fangzhi Yanjiu, 2022 Pituitary adenoma is one common type of intracranial tumors, accounting for about 10% of intracranial tumors. Although pituitary adenomas are benign tumors, the complete resection and recurrence prevention remain challengeable due to aggressive growth of
LEI Ting +5 more
doaj +1 more source
Surgical Complications of Endoscopic Endonasal Trans-Sphenoidal Approach for Pituitary Tumors [PDF]
Al-Azhar International Medical Journal, 2020 Background: Pituitary macro-adenomas form about 10% of intracranial tumors. Most of them are non-functioning and manifestations are due to space-occupying effects or clinical hypo-pituitarism.
Ibrahim Ewis +2 more
doaj +1 more source
Endocrinology and Metabolism Clinics of North America, 2015 Pituitary tumors are commonly encountered intracranial neoplasms that are invariably benign. Classic oncogene mutations are not encountered in these tumors, and disrupted cell cycle control and growth factor signaling likely contribute to pathogenesis and natural history.
openaire +2 more sources
Chinese Journal of Contemporary Neurology and Neurosurgery, 2022 The fourth edition of the latest classification principles for endocrine tumors was published by the World Health Organization (WHO) in 2017. The latest tumor classification and new pathological classification of each pituitary gland tumor were given in ...
GUAN Hong +4 more
doaj +1 more source
The Epigenomics of Pituitary Adenoma
Frontiers in Endocrinology, 2019 Background: The vast majority of pituitary tumors are benign and behave accordingly; however, a fraction are invasive and are more aggressive, with a very small fraction being frankly malignant.
Blake M. Hauser +4 more
doaj +1 more source
Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?
Endocrine Oncology, 2023 Pituitary adenomas are benign neoplasms of the pituitary. The most prevalent are prolactinomas and non-functioning pituitary adenomas, followed by growth hormone-and ACTH-secreting adenomas.
Sandra Pekic +2 more
doaj +1 more source